Care Anywhere, Everywhere: As consumers increasingly expect to receive care how, where and when they want, healthcare is increasingly expanding from hospitals to ambulatory and at-home care locations. The MedTech executives interviewed for the report said that while traditional products continue to drive revenues, the expansion of care to new settings is a key part of their growth strategies.

The Rise of Digital Health: MedTech company leaders are prioritizing digital health by building capabilities in-house through investments in R&D, technology, digital and new business models; and by making asset acquisitions to expand their pipeline across therapeutic areas and add new capabilities to innovate faster or reach customers in new ways. Nearly all (99%) executives indicated that development and commercialization of Digital Health solutions has accelerated in the past two years.

Converging Sectors: The rise of digital in healthcare is also fueling non-traditional deals, with future success dependent upon various sectors converging to develop products and services across the entire care continuum, according to nearly nine out of 10 (86%) executives.
New Regulatory Pathways: Digital Health may fall outside the bounds of established regulatory pathways for untested technologies, requiring new approaches from the sector. Most executives (87%) identified government regulations as a threat and disruptor to their business. This may be due to the shifting nature of regulatory guidelines, as regulatory bodies work to keep up with the rate of new and emerging technologies and ensure they are safe and effective.


About the Research
Accenture surveyed 150 MedTech senior executives globally (Germany, Japan, Netherlands, Switzerland, UK and US). The respondents were equally distributed across 30 med-tech companies with median 2021 global revenues of nearly US$10 billion. Two-thirds of the respondents had a tenure of 11-20 years’ experience in the MedTech industry. Accenture also interviewed 30+ C-suite and other senior executives from the MedTech and pharma sectors in AdvaMed’s Digital Health Center of Excellence to confirm survey findings and gain deeper insights. In addition, the researchers analyzed 100 M&A deals and more than 600 product launches from a subset of MedTech companies that took place between January 2019 and March 2022.


About Accenture
Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services and Accenture Song—all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 721,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities.

Back to HCB News

Business Affairs Homepage